Spatial transcriptomics for neoadjuvant BO-112 and hypofractionated radiation therapy sarcoma
Spatial transcriptomic data from longitudinal tumor samples from one patient undergoing neoadjuvant BO-112 and hypofractionated radiation therapy in soft tissue sarcoma